Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech binary events -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (241)	3/29/2007 6:31:25 AM
From: kenhott	Read Replies (1) \| Respond to of 295

How about "not too terrible" to "better than expected"? :) I personally would like the FDA to let the drug thru with a short leash. I think that is probably the right decision. But I am guessing that the FDA will not do that. Financially, I am positioned so the downside is only a few $s. edit: Actually if I am smart enough to bring down my position the right way, I would make a few bucks with an approval. But I am not counting on that.